West Pharmaceutical Services | WST - Net Income

Stock Price
237.05
Daily Change
6.10 2.64%
Monthly
-15.05%
Yearly
-29.27%
Q1 Forecast
224.00

West Pharmaceutical Services reported $140M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Align Technology USD 135.76M 79.01M Dec/2025
Avanos Medical USD -1.4M 75.4M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Dentsply International USD -427M 382M Sep/2025
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -3.4M 38.73M Sep/2025
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
J&J USD 5.12B 36M Dec/2025
Medtronic USD 1.37B 334M Sep/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Neogen USD -15.92M 52.26M Sep/2025
Quidel USD -733M 477.6M Sep/2025
Repligen USD 14.91M 44K Sep/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
STAAR Surgical USD 8.88M 25.7M Sep/2025
Terumo JPY 35.05B 6.79B Sep/2025
West Pharmaceutical Services USD 140M 8.2M Sep/2025